Saturday, July 24, 2010

Let's cure HIV+ with GcMAF

In the peer reviewed Journal of Medical Virology, 81:16-26 (2009) Dr. Nobuto Yamamoto reports his clinical trial using the potent macrophage activating factor, GcMAF, to reverse HIV+ in 18 weeks or less. The treatment seems to be free of serious side effects. You can stop after a while. Who can fund an FDA approved clinical trial so we can start using it in the USA?

in reference to: BBC News - Scientists say vaginal gel cuts HIV-infections by half (view on Google Sidewiki)

No comments: